SAN DIEGO, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) announced today that it has received CLIA Licensure from the State of California that permits ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback